FDA Approved: IMDELLTRA (AMG757) — Original Application (Amgen, Inc)

View source ↗

Summary

FDA approved IMDELLTRA (AMG757) from Amgen via an original application; tarlatamab-dlle is approved for treating multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• IMDELLTRA (TARLATAMAB-DLLE)

Snippet

ORIG AP for IMDELLTRA (AMG757) (TARLATAMAB-DLLE)